Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marchesoni

Showing results (421-430 of 521) with videos related to

Pageof 53
Sort By:
The Journal of Rheumatology|February 17, 2016
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian StudyValentina Varisco, Mauro Viganò, Alberto Batticciotto, et al.
Lupus|April 9, 2010
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosusJ Nossent, E Kiss, B Rozman, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumabA Armuzzi, P Lionetti, C Blandizzi, et al.
Reumatismo|December 17, 2016
Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA)G Lapadula, A Marchesoni, F Salaffi, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseasesC Blandizzi, P Gionchetti, A Armuzzi, et al.
Journal of Clinical Medicine|January 11, 2022
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE StudyAntonio Marchesoni, Pierluigi Macchioni, Stefania Gasparini, et al.
The Journal of Rheumatology|April 3, 2012
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictorsFlorenzo Iannone, Elisa Gremese, Fabiola Atzeni, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
Adalimumab in the treatment of immune-mediated diseasesG Lapadula, A Marchesoni, A Armuzzi, et al.
Frontiers in Medicine|January 6, 2023
Residual inflammation in psoriatic arthritis patients in stable minimal disease activityPierluigi Macchioni, Antonio Marchesoni, Giovanni Ciancio, et al.
The Journal of Rheumatology|October 24, 2001
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritisC Salvarani, P Macchioni, I Olivieri, et al.
Pageof 53

Showing results (421-430 of 521) with videos related to

Sort By:
Pageof 53
The Journal of Rheumatology|February 17, 2016
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian StudyValentina Varisco, Mauro Viganò, Alberto Batticciotto, et al.
Lupus|April 9, 2010
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosusJ Nossent, E Kiss, B Rozman, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumabA Armuzzi, P Lionetti, C Blandizzi, et al.
Reumatismo|December 17, 2016
Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA)G Lapadula, A Marchesoni, F Salaffi, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseasesC Blandizzi, P Gionchetti, A Armuzzi, et al.
Journal of Clinical Medicine|January 11, 2022
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE StudyAntonio Marchesoni, Pierluigi Macchioni, Stefania Gasparini, et al.
The Journal of Rheumatology|April 3, 2012
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictorsFlorenzo Iannone, Elisa Gremese, Fabiola Atzeni, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
Adalimumab in the treatment of immune-mediated diseasesG Lapadula, A Marchesoni, A Armuzzi, et al.
Frontiers in Medicine|January 6, 2023
Residual inflammation in psoriatic arthritis patients in stable minimal disease activityPierluigi Macchioni, Antonio Marchesoni, Giovanni Ciancio, et al.
The Journal of Rheumatology|October 24, 2001
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritisC Salvarani, P Macchioni, I Olivieri, et al.
Pageof 53